ITC Ltd. RESULT UPDATE 27th October, 2017

Size: px
Start display at page:

Download "ITC Ltd. RESULT UPDATE 27th October, 2017"

Transcription

1 . RESULT UPDATE 27th October, 2017

2 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update - II 27th October, 2017 CMP INR 269 Target INR 349 Potential Upside 29.7% Market Cap (INR Mn) 3,271,309.1 Poor Show Recommendation BUY Sector FMCG Result highlights posted its results which were below our estimates, Net revenue for reported at INR 97,639.2 Mn which de-grew by 28.3% YoY and by 29.2% QoQ. Mainly due Adverse Impact of GST which led to lower revenue from Cigarettes Segment. During H1, ITC posted net revenue of INR 235,643.4 Mn which declined by 12.3% YoY. EBIDTA during the quarter improved to by 1,138 bps QoQ and 1,187 YoY with 38.5% margins and stood at INR 37, During H1 EBITDA was INR 75,079.1 Mn with margins of 31.9, an increase of 523 bps YoY. PAT after exceptional item for stood at INR 26,398.4 Mn and margin at 27% which increased by 822 bps YoY and 848 bps QoQ. 2 MARKET DATA Shares outs (Mn) EquityCap (INR Mn) Mkt Cap (INR Mn) Wk H/L (INR) 353/222 Volume Avg (3m K) Face Value (INR) 1 Bloomberg Code ITC IN SHARE PRICE PERFORMANCE Sensex MARKET INFO SENSEX NIFTY KEY FINANCIALS (INR Mn) FY15 FY16 FY17 E FY19E Gross Sales EBITDA PAT EBITDA Margins % 36.6% 36.9% 36.1% 36.4% 36.8% PAT Margins % 25.1% 24.2% 24.5% 24.8% 24.9% EPS ROE 30.8% 22.3% 22.6% 23.7% 24.4% Poor Show by Cigarette Biz: The result of ITC was very disappointing. We believe that the GST impact and the poor performance of Cigarette segment led to de-growth in the top-line. Though the overall consumer demand is gradually improving post GST implementation but this improvement is not yet witnessed in the Cigarette category which accounts for major revenue share of ITCs total revenue. During the quarter ITC posted net revenue of INR 97,639.2 Mn which decreased by 28.3% YoY from INR 136,166.1 Mn in FY17 and decreased by 29.2% QoQ from 138,004.2 Mn in Q1. During the quarter the Cigarette segment posted revenue of INR 45,542.1 Mn which de-grew by 48.1% QoQ from INR 87,741.6 Mn in Q1 and de-grew by 46.6% YoY from INR 85,284.7 Mn in FY17. The revenue share of Cigarette category witnessed a sharp fall of bps QoQ from 55.5% in Q1 to 41.6% in and bps YoY from 58% in FY17 to 41.6% in, which remains a major concern. The Non-Cigarette FMCG segment witnessed mid-single digit growth during the quarter as well as compared to last year same period. The Non-Cigarette FMCG segment reported net revenue of INR 28,041.1 Mn which increased by 7.8% QoQ and 5% YoY, the revenue share of FMCG segment has increased by 91.8 bps QoQ from 16.5% in Q1 to 25.6% in and by 74.8 bps from 18.2% in FY17 to 25.6% in. The revenue share of Hotels, Agri and Paper segment improved by 8.2 bps, 5.2 bps and 33.7 bps respectively on QoQ basis, while the share increased by 7.2 bps, 52.1 bps and 29.2 bps respectively on YoY basis. During H1 the net revenue stood at INR 233,984.1 Mn which declined by 12.2% YoY from INR 266,480.5 Mn in H1FY17. Expansion in Margin: EBIDTA margins for ITC in were at 38.5% which saw an improvement of 1,138 bps QoQ and 1,187 bps YoY majorly due to stable raw material price and reversal of excise duty during the quarter. Other cost like employee showed 10.1% decline QoQ while it remained stable on YoY basis and other operating cost marginally decreased by 9.6% YoY and 6.4% QoQ. So mix of all these lead to expansion of EBIDTA. In EBIDTA stood at INR Mn with growth of around 3.6% YoY. During H1 EBITDA was INR 75,079.1 Mn which grew by 5% YoY and margins stood at 31.9% which increased by 523 bps YoY. Reported PAT for, was at INR 26,398.4 Mn with growth of 3.0% YoY and QoQ. PAT margins stood at 27.0% in vis-à-vis 18.8% in FY17 and 18.6% in Q1 mainly due to Cost management and operational efficiency. During H1 PAT was INR 52,003.4 Mn which increased by 6.5% YoY and margins stood at 27%, an increase of 822 bps YoY. SHARE HOLDING PATTERN (%) Sep 17 Jun 17 Mar 17 Promoters FIIs DIIs Others Total % 7.7% PAT CAGR between FY15 and Revenue CAGR between FY15 and FY19E FY19E

3 India Equity Institutional Research II Result Update - II 27th October, 2017 Valuations & Views: ITC is an old conglomerated company with its presence across diversify businesses like Cigarettes, FMCG, Hotels, Agri and Paper & Paper products. During, GST has impacted its overall businesses, we believe that cigarettes business would remain under pressure due to high taxation while focus is to grow FMCG and other business which would see growth and improvement in future. However management focus is to diversify its business into FMCG from cigarettes by entering new segment with innovative products. ITC aims to generate around 25-30% revenue from FMCG in next 3-4 years. We believe ITC has created brand image with its strong product portfolio and would post its revenue growth of around 10-12% in E & FY19E with growth driven mainly by its FMCG and other businesses. Its EBIDTA and PAT margins will be stable at around 26.8% and 18.2%, respectively. At the CMP of INR 269, ITC is trading at an EPS of INR 10.8 its FY19E, we recommend BUY rating on the stock, with a target price of INR 349 that offers a potential upside of 29.7%. 3 Result Snapshot Exhibit 1 Quarterly Income Statement (INR Mn) Q1 FY17 Q-o-Q Net Sales & Other Operating Income % -28.3% Total Expenditure % -39.9% Cost of Raw Materials % -4.7% Purchase of Finished Goods % 11.5% (Increase) / Decrease In Stocks % Excise Duty % % Employee Cost % 1.0% Operating & Manufacturing Expenses % -9.6% EBIDTA % 3.6% EBITDA Margins (%) 38.5% 27.1% 26.7% 1138bps 1187bps Depreciation % 5.2% EBIT % 3.5% Other Income % 3.7% Interest % 113.0% PBT % 3.1% Tax % 3.4% PAT before Exceptional % 3.0% PAT Margin (%) 27.0% 18.6% 18.8% 848bps 822bps EPS % 2.8% Exhibit 2 Segmental Revenue (INR Mn) Q1 Q-o-Q FY17 FMCG - Cigarettes % -46.6% FMCG - Others % 5.0% Total FMCG % -34.3% Hotel % 1.0% Agri Business % 4.7% Paperboards, Paper & Packing % -1.7% Total % -25.7%

4 India Equity Institutional Research II Result Update - II 27th October, 2017 Exhibit 3 Segmental EBIT (INR Mn) 4 Q1 FY17 Q-o-Q FMCG - Cigarettes % 1.8% FMCG - Others % % Total FMCG % 3.1% Hotel % 552.3% Agri Business % -13.7% Paperboards, Paper & Packing % 18.2% Total % 2.8% Less: interest Exp % 170.6% Add/Less: (other) % 34.9% PBT % 3.1% Exhibit 4 Segmental EBIT Margins (INR Mn) Q1 FY17 Q-o-Q FMCG - Cigarettes 72.3% 37.3% 37.7% 3496bps 3456bps FMCG - Others 0.7% 0.2% -0.1% 52bps 85bps Total FMCG 45.0% 28.8% 28.7% 1618bps 1632bps Hotel 1.4% 1.7% 0.2% -33bps 119bps Agri Business 13.0% 8.5% 15.8% 450bps -278bps Paperboards, Paper & Packing 20.9% 18.9% 17.4% 3986bps 3836bps Total 72.3% 37.3% 37.7% 3496bps 3456bps Exhibit 5 H1 Income Statement (INR Mn) H1 H1 FY17 Net Sales & Other Operating Income 235, , % Total Expenditure 160, , % Cost of Raw Materials 57, , % Purchase of Finished Goods 15, , % (Increase) / Decrease In Stocks 8, , % Excise Duty 32, , % Employee Cost 12, , % Operating & Manufacturing Expenses 32, , % EBIDTA 75, , % EBITDA Margins (%) 31.9% 26.6% 523bps Depreciation 5, , % EBIT 69, , % Other Income 9, , % Interest % PBT 78, , % Tax 26, , % PAT after Exceptional 52, , % PAT Margin (%) 27.0% 18.6% 848bps EPS %

5 India Equity Institutional Research II Result Update - II 27th October, 2017 Exhibit 6 - Income Statement (INR Mn) 5 (INR Mn) FY15 FY16 FY17 E FY19E Gross Sales EXPENDITURE : Cost of Materials Consumed Purchase of Stock In Trade (Increase) / Decrease In Stocks Total RM Costs Excise Duty Employee Cost Other Expenses Total Expenditure Operating Profit (EBIDTA) EBIDTA Margin % 26.7% 26.2% 26.3% 26.5% 26.8% Depreciation Operating Profit (EBIT) Other Income Interest Profit before Tax Provision for Tax Profit After Tax PAT Margin % 18.4% 17.2% 17.8% 18.1% 18.2% Exhibit 7- Segmental Revenue Share (%) FY17 Cigarettes 41.6% Paper 12.0% FMCG 25.6% Agri 18.0% Hotel 2.7% Cigarettes 58.0% FMCG 18.2% Agri 12.8% Paper 9.1% Hotel 2.0%

6 India Equity Institutional Research II Result Update - II 27th October, 2017 Exhibit 8 - Balance Sheet (INR Mn) 6 (INR Mn) FY15 FY16 FY17 E FY19E EQUITY AND LIABILITIES Share Capital Total Reserves Shareholder's Funds Minority Interest Long-Term Borrowings Deferred Tax Assets / Liabilities Long Term Provisions Other Long Term Liabilities Total Non-Current Liabilities Current Liabilities Trade Payables Short Term Borrowings Short Term Provisions Other Current Liabilities Total Current Liabilities Total Liabilities ASSETS Non-Current Assets Net Block Capital Work in Progress Godwill on consolidation Non Current Investments Deffered tax assets Long Term Loans & Advances Other Non Current Assets Total Non-Current Assets Current Assets Inventories Sundry Debtors Cash and Bank Currents Investments Short Term Loans and Advances Other Current Assets Total Current Assets Total Assets

7 India Equity Institutional Research II Result Update - II 27th October, 2017 Exhibit 9 - Cash flow statement (INR Mn) 7 (INR Mn) FY15 FY16 FY17 E FY19E PBT Add: Depreciation Add: Interest Cash flow from Operations Cash flow from Investing Activity Cash flow from Financing Activity Net change in Cash (Inflow/Outflow) Total Cash & Bank Balance Exhibit 10 - Ratio Analysis FY15 FY16 FY17 E FY19E EPS BV DPS EBITDA Margin (%) 36.6% 36.9% 36.1% 36.4% 36.8% PAT Margin (%) 25.1% 24.2% 24.5% 24.8% 24.9% Net Sales Growth % 8.9% 0.9% 9.2% 10.0% 12.0% EBIDTA Growth % -4.4% 1.8% 6.8% 11.1% 13.2% PAT Growth % -9.5% -2.7% 10.2% 11.7% 12.5% PE (x) Price/BV EV/EBITDA EV/Sales ROE (%) 30.8% 22.3% 22.6% 23.7% 24.4% ROCE % 29.7% 27.4% 26.5% 27.4% 28.8% Debt/Equity % 0.8% 0.3% 0.2% 0.2% 0.2%

8 India Equity Institutional Research II Result Update - II 27th October, Rating Legend Date CMP (INR) TP (INR) Recommendation Our Rating Upside 27-Oct BUY 27-Jul BUY Buy More than 15% 26-May ACCUMULATE 27-Jan BUY Accumulate 5% 15% 26-Oct BUY 22-July * 351 BUY Hold 0 5% 20-May BUY 20-Apr BUY Reduce -5% 0 22-Jan BUY 12-Jan BUY Sell Less than 5% *Note: Split in ratio 3:2 from 1 st July, CERTIFICATION: We, Nirvi Ashar (B.com, MBA), research analyst and Kunal Jagda (B.com, MBA), research associate, author and the name subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect my views about the subject issuer(s) or securities. I also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Terms & Conditions and other disclosures: KRChoksey Shares and Securities Pvt. Ltd (hereinafter referred to as KRCSSPL) is a registered member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited and MCX Stock Exchange Limited. KRCSSPL is a registered Research Entity vides SEBI Registration No. INH under SEBI (Research Analyst) Regulations, We submit that no material disciplinary action has been taken on KRCSSPL and its associates (Group Companies) by any Regulatory Authority impacting Equity Research Analysis activities. KRCSSPL prohibits its analysts, persons reporting to analysts and their relatives from maintaining a financial interest in the securities or derivatives of any companies that the analyst covers. The information and opinions in this report have been prepared by KRCSSPL and are subject to change without any notice. The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of KRCSSPL. While we would endeavor to update the information herein on a reasonable basis, KRCSSPL is not under any obligation to update the information. Also, there may be regulatory, compliance or other reasons that may prevent KRCSSPL from doing so. Non-rated securities indicate that rating on a particular security has been suspended temporarily and such suspension is in compliance with applicable regulations and/or KRCSSPL policies, in circumstances where KRCSSPL might be acting in an advisory capacity to this company, or in certain other circumstances. This report is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its accuracy or completeness guaranteed. This report and information herein is solely for informational purpose and shall not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. KRCSSPL will not treat recipients as customers by virtue of their receiving this report. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any recipient. The recipient should independently evaluate the investment risks. The value and return on investment may vary because of changes in interest rates, foreign exchange rates or any other reason. KRCSSPL accepts no liabilities whatsoever for any loss or damage of any kind arising out of the use of this report. Past performance is not necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice. Our employees in sales and marketing team, dealers and other professionals may provide oral or written market commentary or trading strategies that reflect opinions that are contrary to the opinions expressed herein,.in reviewing these materials, you should be aware that any or all of the foregoing, among other things, may give rise to real or potential conflicts of interest. Associates (Group Companies) of KRCSSPL might have received any commission/compensation from the companies mentioned in the report during the period preceding twelve months from the date of this report for services in respect of brokerage services or specific transaction or for products and services other than brokerage services. KRCSSPL or its Associates (Group Companies) have not managed or co-managed public offering of securities for the subject company in the past twelve months KRCSSPL encourages the practice of giving independent opinion in research report preparation by the analyst and thus strives to minimize the conflict in preparation of research report. KRCSSPL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither KRCSSPL nor Research Analysts have any material conflict of interest at the time of publication of this report. It is confirmed that, Nirvi Ashar (B.com, MBA), research analyst and Kunal Jagda (B.com, MBA), research associate, of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months. Compensation of our Research Analysts is not based on any specific brokerage service transactions. KRCSSPL or its associates (Group Companies) collectively or its research analyst do not hold any financial interest/beneficial ownership of more than 1% (at the end of the month immediately preceding the date of publication of the research report) in the company covered by Analyst, and has not been engaged in market making activity of the company covered by research analyst. It is confirmed that, Nirvi Ashar (B.com, MBA), research analyst and Kunal Jagda (B.com, MBA), research associate, do not serve as an officer, director or employee of the companies mentioned in the report. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other Jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject KRCSSPL and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform them of and to observe such restriction. Please send your feedback to research.insti@krchoksey.com Visit us at Kisan Ratilal Choksey Shares and Securities Pvt. Ltd Registered Office: 1102, Stock Exchange Tower, Dalal Street, Fort, Mumbai Phone: ; Fax: Corporate Office: ABHISHEK, 5th Floor, Link Road, Andheri (W), Mumbai Phone: ; Fax:

Symphony Ltd. RESULT UPDATE 31st October 2017

Symphony Ltd. RESULT UPDATE 31st October 2017 . RESULT UPDATE 31st October 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update Q2FY18 II 31st October 2017. CMP INR 1,465 Target INR 1,700 Potential

More information

Nestle India Ltd. RESULT UPDATE

Nestle India Ltd. RESULT UPDATE RESULT UPDATE 15th May 2017 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 India Equity Institutional Research II Result Update Q1CY17 II 15th May, 2017 CMP INR 6819 Target INR 7075 Potential Upside

More information

Colgate-Palmolive India Ltd.

Colgate-Palmolive India Ltd. RESULT UPDATE 5th February, 2018 Feb-15 Aug-15 Feb-16 Aug-16 Feb-17 Aug-17 Feb-18 India Equity Institutional Research II Result Update - Q3FY18 II 5th February, 2018 CMP INR 1,120 MARKET DATA Target INR

More information

Hindustan Unilever Ltd.

Hindustan Unilever Ltd. . RESULT UPDATE 18 th July 2017 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 Jul-17 125 105 India Equity Institutional Research II Result Update - FY18 II 18th July, 2017 CMP INR 1158 Target INR 1206 MARKET

More information

Britannia Industries Ltd.

Britannia Industries Ltd. . RESULT UPDATE 30th May, 2017 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 India Equity Institutional Research II Result Update - Q4FY17 II 30 th May, 2017 2 Growth Path ahead CMP INR 3419 Target

More information

Prabhat Dairy Ltd. RESULT UPDATE 8th June, 2018

Prabhat Dairy Ltd. RESULT UPDATE 8th June, 2018 RESULT UPDATE 8 th June, 2018 Sep-15 Jan-16 May-16 Sep-16 Jan-17 May-17 Sep-17 Jan-18 May-18 India Equity Institutional Research II Result Update - Q4FY18 II 8 th June, 2018 2 Under Expansion Mode CMP

More information

Britannia Industries Ltd.

Britannia Industries Ltd. . RESULT UPDATE 9th August, 2017 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Please vote for us in Asiamoney Brokers Poll 2017: https://www.euromoney.com/article/b13j49qfcr6j pp/asiamoney-brokers-poll-2017-vote-now

More information

Hindustan Unilever Ltd.

Hindustan Unilever Ltd. . RESULT UPDATE 25th October 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update - II 25th October 2017 CMP INR 1273 Target INR 1392 Potential Upside

More information

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017 RESULT UPDATE 16 th August, 2017 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Please vote for us in Asiamoney Brokers Poll 2017: https://www.euromoney.com/article/b13j49qfcr6j pp/asiamoney-brokers-poll-2017-vote-now

More information

Tata Consultancy Services

Tata Consultancy Services Tata Consultancy Services SALES NOTE 19 th May 2017 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 India Equity Institutional Research II Sales Note II 19th May, 2017 CMP INR 2536 Target INR 2833 Potential

More information

Balkrishna Industries Ltd

Balkrishna Industries Ltd RESULT UPDATE 3 rd August 2017 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Please vote for us in Asiamoney Brokers Poll 2017: https://www.euromoney.com/article/b13j49qfcr6j pp/asiamoney-brokers-poll-2017-vote-now

More information

Infibeam Incorporation Ltd.

Infibeam Incorporation Ltd. RESULT UPDATE 16 th August, 2017 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Please vote for us in Asiamoney Brokers Poll 2017: https://www.euromoney.com/article/b13j49qfcr6j pp/asiamoney-brokers-poll-2017-vote-now

More information

Bharat Forge Ltd RESULT UPDATE

Bharat Forge Ltd RESULT UPDATE RESULT UPDATE 9 th November 2017 Nov-14 May-15 Nov-15 May-16 Nov-16 May-17 Nov-17 160 130 100 India Equity Institutional Research II Result Update Q2FY18 II 9 th November, 2017 CMP INR 738 Target INR 840

More information

Persistent Systems Ltd.

Persistent Systems Ltd. RESULT UPDATE 26 th April2017 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 India Equity Institutional Research II Result Update - Q4FY17 II 26th April, 2017 2 Investment Mode Off, Return Mode On CMP INR 564 Target

More information

Godrej Consumer Products Ltd.

Godrej Consumer Products Ltd. RESULT UPDATE 1st August, 2017 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 India Equity Institutional Research II Result Update Q1FY18 II 1st August, 2017 CMP INR 1,035 Target INR 1,120 Potential

More information

Bharat Forge Ltd RESULT UPDATE

Bharat Forge Ltd RESULT UPDATE RESULT UPDATE 11 th August 2017 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Please vote for us in Asiamoney Brokers Poll 2017: https://www.euromoney.com/article/b13j49qfcr6j pp/asiamoney-brokers-poll-2017-vote-now

More information

Tech Mahindra Ltd. RESULT UPDATE

Tech Mahindra Ltd. RESULT UPDATE Ltd. RESULT UPDATE 29 th May 2017 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 India Equity Institutional Research II Result Update - Q4FY17 II 29 th May, 2017 CMP INR 374 Target INR 473 Potential

More information

Sagar Cements Ltd. Management Meet Update

Sagar Cements Ltd. Management Meet Update Management Meet Update 26th September, 2017 Sep-14 Mar-15 Sep-15 Mar-16 Sep-16 Mar-17 Sep-17 India Equity Institutional Research II Management Meet Update II 26th September, 2017 2 Robust earnings outlook!

More information

HCL Technologies Ltd.

HCL Technologies Ltd. RESULT UPDATE 12 th May 2017 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 India Equity Institutional Research II Result Update - Q4FY17 II 12 th May, 2017 CMP INR 839 Target INR 1068 Potential Upside

More information

Bharat Forge Ltd RESULT UPDATE

Bharat Forge Ltd RESULT UPDATE RESULT UPDATE 25 th May 2017 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 India Equity Institutional Research II Result Update - Q4FY17 II 25th May, 2017 2 Pricey valuation limits further upside CMP

More information

Tech Mahindra Ltd. RESULT UPDATE

Tech Mahindra Ltd. RESULT UPDATE Ltd. RESULT UPDATE 1 st August, 2017 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 India Equity Institutional Research II Result Update - Q1FY18 II 1st August, 2017 CMP INR 403 MARKET DATA Target INR

More information

Lupin Ltd. RESULT UPDATE 31 st October 2017

Lupin Ltd. RESULT UPDATE 31 st October 2017 RESULT UPDATE 31 st October 217 22 nd May 217 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update Q2FY18 II 31st October, 217 Lupin Ltd CMP INR 127 Target

More information

Page. ICICI Bank Ltd. RESULT UPDATE 31 st July, 2017

Page. ICICI Bank Ltd. RESULT UPDATE 31 st July, 2017 1. RESULT UPDATE 31 st July, 2017 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 Jul-17 India Equity Institutional Research II Result Update Q1FY18 II 31st July, 2017 2 Asset quality still worrisome, slippages

More information

Reliance Industries Ltd.

Reliance Industries Ltd. 1. RESULT UPDATE 22 nd January, 2018 Jan-15 Jul-15 Jan-16 Jul-16 Jan-17 Jul-17 Jan-18 India Equity Institutional Research II Result Update Q3FY18 II 22nd January, 2018 CMP INR 929 Result highlights Target

More information

Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd. Sun Pharmaceutical Industries Ltd. RESULT UPDATE 14th August 2017 22 nd May 2017 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Please vote for us in Asiamoney Brokers Poll 2017: https://www.euromoney.com/article/b13j49qfcr6j

More information

Lupin Ltd. RESULT UPDATE

Lupin Ltd. RESULT UPDATE RESULT UPDATE 3rd August 217 22 nd May 217 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Please vote for us in Asiamoney Brokers Poll 217: https://www.euromoney.com/article/b13j49qfcr6j pp/asiamoney-brokers-poll-217-vote-now

More information

Page. Mahanagar Gas Ltd. RESULT UPDATE 8 th August, 2018

Page. Mahanagar Gas Ltd. RESULT UPDATE 8 th August, 2018 1 RESULT UPDATE 8 th August, 2018 Jul-16 Jan-17 Jul-17 Jan-18 Jul-18 India Equity Institutional Research II Result Update Q1FY19 II 8 th August, 2018 2 CMP INR 961 Target INR 1,165 Potential Upside 21.2%

More information

Page. ICICI Bank Ltd. RESULT UPDATE 30 th October, 2017

Page. ICICI Bank Ltd. RESULT UPDATE 30 th October, 2017 1. RESULT UPDATE 30 th October, 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update Q2FY18 II 30th October, 2017 2 Stress situation continues to improve

More information

Cipla Ltd. RESULT UPDATE

Cipla Ltd. RESULT UPDATE RESULT UPDATE 14th August 2017 22 nd May 2017 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Please vote for us in Asiamoney Brokers Poll 2017: https://www.euromoney.com/article/b13j49qfcr6j pp/asiamoney-brokers-poll-2017-vote-now

More information

Kotak Mahindra Bank Ltd.

Kotak Mahindra Bank Ltd. 1. RESULT UPDATE 26 th October, 2017 Oct/14 Apr/15 Oct/15 Apr/16 Oct/16 Apr/17 Oct/17 India Equity Institutional Research II Result Update Q2FY18 II 26 th October, 2017 CMP INR 1014 Target INR 1104 Result

More information

Visaka Industries Ltd

Visaka Industries Ltd Company Update Superior Product Mix & New Age Markets to Aid Growth New investments to aid growth: Visaka continues to give a good set of numbers. YoY EPS grew at 142% aided by a revenue growth of 1.5%

More information

Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd 1 Sun Pharmaceutical Industries Ltd Event Update 23 rd March, 2018 Mar-15 Sep-15 Mar-16 Sep-16 Mar-17 Sep-17 Mar-18 India Equity Institutional Research II Event Update II 23 rd March, 2018 2 CMP INR 508

More information

Fineotex Chemical Ltd

Fineotex Chemical Ltd Company Update Decent Performance under Macroeconomic Pressure; Business Traction to Continue: Fineotex Chemical recorded decent set of result as consolidated sales grew by 1.1% YoY (largely in line) to

More information

Cummins India Ltd Bloomberg Code: KKC IN

Cummins India Ltd Bloomberg Code: KKC IN Company Update Margins Under Pressure; Domestic Recovery Underway Half-yearly revenue was flat; margins were under pressure: Cummins India revenue, EBITDA and PAT for H1FY17 reached to Rs.24,784mn, Rs.4,649mn

More information

Ultratech Ltd. RESULT UPDATE

Ultratech Ltd. RESULT UPDATE Ultratech Ltd. RESULT UPDATE 26th April 2017 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 India Equity Institutional Research II Result Update - Q4FY17 II 26th April, 2017 CMP INR 4238 Target INR 4266 Potential

More information

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E Company Update Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E EBITDA Margins recovered by 618 bps QoQ: The company has witnessed many challenges over the year FY17 starting

More information

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months 3QFY2017 Result Update FMCG January 30, 2017 ITC Performance Highlights Quarterly result (Standalone) (` cr) 3QFY17 3QFY16 % yoy 2QFY17 %qoq Revenue 9,248 8,867 4.3 9,661 (4.3) EBITDA 3,546 3,475 2.1 3,630

More information

D-Link India (DLILIM) 105

D-Link India (DLILIM) 105 Company Update Rating matrix Rating : Buy Target : 140 Target Period : 18-24 months Potential Upside : 34% What s Changed? Target Changed from 150 to 140 EPS FY18E Changed from 11.4 to 9.5 EPS FY19E Introduced

More information

Solar Industries India Ltd

Solar Industries India Ltd RESULT UPDATE 15 th May, 2018 May-15 Nov-15 May-16 Nov-16 May-17 Nov-17 May-18 India Equity Institutional Research II Result Update - Q4FY18 II 15 th May, 2018 CMP INR 1091 Target INR 1353 Potential Upside

More information

Ahluwalia Contracts (India)

Ahluwalia Contracts (India) May-14 Jul-14 Aug-14 Sep-14 Oct-14 Dec-14 Jan-15 Feb-15 Apr-15 May-15 India Research Infrastructure May 22, 215 QUARTERLY REVIEW Bloomberg: AHLU IN Reuters: AHLU.BO BUY Better performance ahead ACIL posted

More information

Hindustan Unilever (RHS)

Hindustan Unilever (RHS) Jul-14 Aug-14 Oct-14 Nov-14 Dec-14 Feb-15 Mar-15 Apr-15 Jun-15 Jul-15 India Research FMCG July 22, 2015 QUARTERLY REVIEW Bloomberg: HUVR IN Reuters: HLL.BO SELL Higher A&P drove volume growth HUL s Q1FY16

More information

Praj Industries (PRAIN)

Praj Industries (PRAIN) Result Update October 18, 211 Rating matrix Rating : Buy Target : 96 Target Period : 12-15 months Potential Upside : 25% WHAT S CHANGED Praj Industries (PRAIN) 77 Key Financials Crore FY1 FY11 FY12E FY13E

More information

Bajaj Finserv (BAFINS) 5443

Bajaj Finserv (BAFINS) 5443 Aug-17 Jun-17 Apr-17 Feb-17 Dec-16 Oct-16 Aug-16 May-16 Mar-16 Jan-16 Nov-15 Sep-15 Company Update Rating matrix Rating Buy Target 6000 Target Period 12 months Potential Upside 10% What s Changed? Target

More information

Bajaj Finserv (BAFINS) 4375

Bajaj Finserv (BAFINS) 4375 Company Update Rating matrix Rating Buy Target 4900 Target Period 12 months Potential Upside 12% What s Changed? Target Changed from 3620 to 4900 EPS FY17E Changed from 146.2 to 150.3 EPS FY18E Changed

More information

Minda Industries Ltd RESULT UPDATE

Minda Industries Ltd RESULT UPDATE RESULT UPDATE 22 nd May 2017 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 India Equity Institutional Research II Result Update - Q4FY17 II 22 nd May, 2017 CMP INR 568 Target INR 678 Potential Upside

More information

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS. Jan-14 Mar-14 Apr-14 May-14 Jul-14 Aug-14 Sep-14 Nov-14 Dec-14 Jan-15 India Research Infrastructure April 10, 2015 EVENT UPDATE Bloomberg: IN Reuters: HCNS.BO BUY QIP step in the right direction has successfully

More information

Wabco India (WABTVS) Having a safe and brake free ride! Management Meet Note. ICICI Securities Ltd Retail Equity Research.

Wabco India (WABTVS) Having a safe and brake free ride! Management Meet Note. ICICI Securities Ltd Retail Equity Research. Management Meet Note Rating matrix Rating : Buy Target : 6750 Target Period : 12 months Potential Upside : 14% What s Changed? Target Changed from 6400 to 6750 EPS FY17E Unchanged EPS FY18E Unchanged Rating

More information

Bajaj Finserv (BAFINS) 3130

Bajaj Finserv (BAFINS) 3130 Company Update Rating matrix Rating Buy Target 3470 Target Period 12 months Potential Upside 11% What s Changed? Target Changed from 2900 to 3470 EPS FY17E EPS FY18E EPS FY19E Introducing at 242.3 Rating

More information

ITC. 1QFY18 Result Update Higher Excise duty impacts sales; healthy EBITDA margin. Sector: FMCG CMP: ` 289. Recommendation: BUY

ITC. 1QFY18 Result Update Higher Excise duty impacts sales; healthy EBITDA margin. Sector: FMCG CMP: ` 289. Recommendation: BUY ITC 1QFY18 Result Update Higher Excise duty impacts sales; healthy EBITDA margin Sector: FMCG CMP: ` 289 Recommendation: BUY Market statistics Current stock price (`) 289 Shares O/S (cr.) 1216.2 Mcap (`cr)

More information

Simplex Infrastructures

Simplex Infrastructures May-14 Jul-14 Aug-14 Sep-14 Nov-14 Dec-14 Jan-15 Mar-15 Apr-15 May-15 India Research Infrastructure May 27, 2015 QUARTERLY REVIEW Bloomberg: SINF IN Reuters: SINF.BO HOLD Working capital ease to improve

More information

IndusInd Bank (INDBA) 1717

IndusInd Bank (INDBA) 1717 Event Update Rating matrix Rating : Buy Target : 1920 Target Period : 12 months Potential Upside : 12% What s Changed? Target EPS FY18E EPS FY19E Rating Price chart October 16, 2017 IndusInd Bank (INDBA)

More information

Reliance Capital (RELCAP)

Reliance Capital (RELCAP) Event Update Rating matrix Rating : Buy Target : 466 Target Period : 12 months Potential Upside : 41% Key Financials (Consolidated) crore FY10 FY11 FY12E FY13E Revenues 6141 5499 6452 7129 PBT 592 287.3

More information

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance 2QFY19 Result Update Gillette India 13 February 2019 Reuters: GILE.NS; Bloomberg: GILL IN Marketing Investments Mask Improved Top-line Performance Gillette India s (GILL) 2QFY19 operating and net earnings

More information

I Direct. nstinct. September 19, 2017

I Direct. nstinct. September 19, 2017 I Direct nstinct September 19, 2017 I-direct Instinct Key risks to investing in I-direct Instinct It is a quick pitch note, which captures the essence of an idea in brief Instinct idea may be based on

More information

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart 4QFY216 Result Update Capital Goods May 11, 216 Inox Wind Performance Highlights Quarterly Data (Consolidated) ( ` cr) 4QFY16 4QFY15 % chg (yoy) 3QFY16 % chg (qoq) Total Income 1,829 93 96.6 941 94.2 EBITDA

More information

Cement. Pet coke ban to dent margins in short-term. Sector Update. ICICI Securities Ltd Retail Equity Research. November 20, 2017

Cement. Pet coke ban to dent margins in short-term. Sector Update. ICICI Securities Ltd Retail Equity Research. November 20, 2017 Sector Update Sectoral View Cement Positive Rating matrix Companies Rating Target Price Old Revised Old Revised Shree Cement Hold Hold 19700 19000 JK Lakshmi Cement Buy Buy 495 470 Mangalam Cement Buy

More information

ITC Ltd. BUY CMP (Rs.) 304 Target (Rs.) 336 Potential Upside(%) 11% Valuation: Investment Rationale. For private circulation only

ITC Ltd. BUY CMP (Rs.) 304 Target (Rs.) 336 Potential Upside(%) 11% Valuation: Investment Rationale. For private circulation only Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18. Volume No.. I Issue No. 186 ITC Ltd September 21, 2018 BSE Code: 500875 NSE Code: ITC Reuters Code: ITC.NS Bloomberg

More information

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights JK 20 NOV 2017 Quarterly Update BUY Target Price: Rs 1,220 White cement steals the show JK Cement s (JKCE) Q2FY18 EBITDA at Rs 2.1 bn (up 30% YoY) was higher than our and consensus estimates, mainly due

More information

Schaeffler India (FAGBEA) 4800

Schaeffler India (FAGBEA) 4800 Event update Rating Matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Stock Data Particular Amount Market Capitalization ( crore) 7,968 Net Debt (CY16) ( crore) (640.6) Net Worth

More information

Reliance Capital (RELCAP) 549

Reliance Capital (RELCAP) 549 Company Update Rating matrix Rating Buy Target 718 Target Period 12 months Potential Upside 31% Key Financials crore FY16E FY17E FY18E FY19E Revenues 9998 16776 18727 21501 PBT 1733 1459 1974 2560 Adjusted

More information

I Direct. nstinct. November 27, 2017

I Direct. nstinct. November 27, 2017 I Direct nstinct November 27, 2017 I-direct Instinct Key risks to investing in I-direct Instinct It is a quick pitch note, which captures the essence of an idea in brief Instinct idea may be based on management

More information

Religare Investment Call

Religare Investment Call v-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 v-18 Q2FY19 Result Update Q2FY19 Result Update BUY CMP (Rs) 5,813 Target Price (Rs) 6,519 Potential Upside 12.1% Sensex

More information

Pidilite Industries Ltd

Pidilite Industries Ltd Company Update De-stocking as an initial response to GST implementation caused subdued performance; Brighter long term business prospects ahead The company has recorded sales of Rs. 16693 Mn in as against

More information

Lumax Industries (LUMIND)

Lumax Industries (LUMIND) Management Meet Note Rating matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Key Financials Crore FY14 FY15 FY16 FY17 Net Sales 1,117 1,143 1,255 1,300 EBITDA 51 59 89 100 Net

More information

Reliance Housing Finance

Reliance Housing Finance Sep-17 Jun-17 Apr-17 Feb-17 Dec-16 Oct-16 Aug-16 Jun-16 Apr-16 Jan-16 Nov-15 Sep-15 Management Meet Rating matrix (Reliance Housing Finance) Rating Listing 115-120 Target Period Potential Upside Key financials

More information

Religare Investment Call

Religare Investment Call v-17 v-17 Dec-17 Jan-18 Jan-18 Feb-18 Mar-18 Mar-18 Apr-18 May-18 May-18 Jun-18 Jul-18 Aug-18 Aug-18 Sep-18 Oct-18 Oct-18 Q2FY19 Result Update Q2FY19 Result Update BUY CMP (Rs) 282 Target Price (Rs) 321

More information

Hindustan Unilever. Q4FY18 Result Update Strong volume growth on weak base and uptick in rural. Sector: FMCG CMP: ` 1,516. Recommendation: HOLD

Hindustan Unilever. Q4FY18 Result Update Strong volume growth on weak base and uptick in rural. Sector: FMCG CMP: ` 1,516. Recommendation: HOLD Hindustan Unilever QFY18 Result Update Strong volume growth on weak base and uptick in rural Sector: FMCG CMP: ` 1,1 Recommendation: HOLD Market Statistics Current stock price (`) 1,1 Shares O/S (cr.)

More information

Hindustan Media Ventures

Hindustan Media Ventures 2QFY216 Result Update Media October 27, 215 Hindustan Media Ventures Performance Highlights Quarterly Data (` cr) 2QFY16 2QFY15 % yoy 1QFY15 % qoq Revenue 227 2 13.7 224 1.4 EBITDA 52 39 33.1 55 (4.5)

More information

Gillette India. Institutional Equities. 1QFY18 Result Update

Gillette India. Institutional Equities. 1QFY18 Result Update 1QFY18 Result Update Institutional Equities Gillette India 14 November 2017 Reuters: GILE.NS; Bloomberg: GILL IN Robust Growth In Operating Margin Gillette India s or GIL s overall top-line performance

More information

Colgate-Palmolive. Q1FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,083. Recommendation: HOLD

Colgate-Palmolive. Q1FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,083. Recommendation: HOLD Colgate-Palmolive Q1FY18 Result Update Volume pressure continues; Soft A&P aids Margin Sector: FMCG CMP: ` 1,083 Recommendation: HOLD Market Statistics Current stock price (`) 1,083 Shares O/S (cr.) 27.2

More information

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1% 4QFY18 Result Update Institutional Equities ITC 17 May 2018 Reuters: ITC.NS; Bloomberg: ITC IN Tracking Expectations ITC s growth in 4QFY18 was modest and in line with expectations. On the revenue side,

More information

DCB Bank (DCB) 208. Healthy fundamentals priced in. Company Update. ICICI Securities Ltd Retail Equity Research. June 13, 2017

DCB Bank (DCB) 208. Healthy fundamentals priced in. Company Update. ICICI Securities Ltd Retail Equity Research. June 13, 2017 Company Update Rating matrix Rating : Hold Target : 200 Target Period : 12 months Potential Upside : -4% What s Changed? Target Changed from 165 to 200 EPS FY18E EPS FY19E Rating Key Financials Crore FY16

More information

Monte Carlo Fashions (MONCAR) 580

Monte Carlo Fashions (MONCAR) 580 Analyst Meet Note December 13, 217 Rating matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Key Financials ( Crore) FY14 FY15 FY16 FY17 Net Sales 53.1 582.6 621.5 584.1 EBITDA

More information

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months 2QFY217 Result Update Textile November 16, 216 Garware Wall Ropes Performance Highlights Quarterly Data (`cr) 2QFY17 2QFY16 % yoy 1QFY17 % qoq Revenue 232 214 8.5 225 3.3 EBITDA 4 26 5.9 31 29.4 Margin

More information

Colgate-Palmolive (India)

Colgate-Palmolive (India) Result Update Colgate-Palmolive (India) 27 July 218 Reuters: COLG.BO; Bloomberg: CLGT IN Tough Times Continue Colgate-Palmolive (India) or CLGT reported a mixed earnings performance in. Volume and revenue

More information

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE 2QFY18 Result Update Institutional Equities Swaraj Engines 13 November 2017 Reuters: SWAR.BO; Bloomberg: SWE IN Strong Realisation Drives Earnings Growth Swaraj Engines (SEL) 2QFY18 earnings were 5% above

More information

Amber Enterprises India Ltd

Amber Enterprises India Ltd 3QFY2019 Result Update Consumer Durable February 16, 2019 Amber Enterprises India Ltd Performance Update (` cr) 3QFY19 3QFY18 % yoy 2QFY19 % qoq Revenue 388.8 338.4 14.9 226.3 71.8 EBITDA 22.1 24.1 (8.2)

More information

Punjab National Bank

Punjab National Bank Nov-14 Dec-14 Jan-15 Mar-15 Apr-15 May-15 Jul-15 Aug-15 Sep-15 Nov-15 India Research Banking November 09, 2015 QUARTERLY REVIEW Bloomberg: PNB IN Reuters: PNBK.BO SELL Asset quality improves but recovery

More information

Union Bank of India (UNIBAN)

Union Bank of India (UNIBAN) Result Update Rating matrix Rating : Hold Target : 22 Target Period : 12 months Potential Upside : 5 % Key Financials crore FY1 NII 4192 6216 714 8312 PPP 3659 435 496 552 PAT 275 282 1915 2439 Valuation

More information

I Direct. nstinct. February 7, 2018

I Direct. nstinct. February 7, 2018 I Direct nstinct February 7, 2018 I-direct Instinct Key risks to investing in I-direct Instinct It is a quick pitch note, which captures the essence of an idea in brief Instinct idea may be based on management

More information

FY17 FY18 FY19E FY20E

FY17 FY18 FY19E FY20E 3-Aug-15 3-Oct-15 3-Dec-15 3-Feb-16 3-Apr-16 3-Jun-16 3-Aug-16 3-Oct-16 3-Dec-16 3-Feb-17 3-Apr-17 3-Jun-17 3-Aug-17 3-Oct-17 3-Dec-17 3-Feb-18 3-Apr-18 3-Jun-18 Result Update STRONG BUY * August 6, 218

More information

Procter & Gamble Hygiene & Health Care

Procter & Gamble Hygiene & Health Care 3QFY216 Result Update FMCG May 6, 216 Procter & Gamble Hygiene & Health Care Performance Highlights Quarterly Data (` cr) 3QFY16 3QFY15 % yoy 2QFY16 % qoq Revenue 614 555 1.5 714 (14.) EBITDA 133 123 8.5

More information

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights AMBUJA S 4 MAY 2017 Quarterly Update HOLD Target Price: Rs 232 Margins to improve from Q2 Q1CY17standalone EBITDA at Rs 4.0 bn was in line withconsensus estimate.volume was up 3% YoY to 6 mnt. Realization

More information

Healty cigarette-driven growth

Healty cigarette-driven growth INDUSTRY FMCG CMP (as on 27 Jul 2017) Rs 289 Target Price Rs 353 Nifty 10,021 Sensex 32,383 KEY STOCK DATA Bloomberg ITC IN No. of Shares (mn) 12,161 12,162 MCap (Rs bn)/(us$ mn) 3,509/54,743 6m avg traded

More information

Vakrangee Ltd BUY. Speciality Retail. Company Update. Aug 07, Vakrangee Ltd. Recommendation (Rs.)

Vakrangee Ltd BUY. Speciality Retail. Company Update. Aug 07, Vakrangee Ltd. Recommendation (Rs.) Company Update Speciality Retail Addition of Service Offerings will Ramp up the Business PAT increased by 38.3% YoY on strong revenue growth: During Q1FY18, the revenue stood at Rs. 13047 Mn as against

More information

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E. At inflection point Q2FY18 adjusted PAT grew 12% YoY at Rs 27 bn (vs. our estimate Rs 26 bn) in tandem with 17% YoY rise in regulated equity. Core RoE is still healthy at 20.2% though it contracted ~174

More information

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 2904 Recommendation CMP Target Price BUY Rs. 312 Rs. 443 Better times ahead! reported a good set of numbers in

More information

Mahindra & Mahindra. Source: Company Data; PL Research

Mahindra & Mahindra. Source: Company Data; PL Research Tractors drive Q2 performance; Accumulate November 11, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating Accumulate Price Rs1,242 Target Price Rs1,503 Implied Upside 21.0% Sensex 26,819 Nifty

More information

Emmbi Industries (EMMPOL)

Emmbi Industries (EMMPOL) Management Meet Note Rating Matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Key Financials Crore Net Sales 2.2 139.7 157.9 182.6 EBITDA 9.8 12.6 15.3 19.7 Net Profit 3.3 3.2

More information

Colgate-Palmolive. Q2FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,063. Recommendation: HOLD

Colgate-Palmolive. Q2FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,063. Recommendation: HOLD Colgate-Palmolive Q2FY18 Result Update Volume pressure continues; Soft A&P aids Margin Sector: FMCG CMP: ` 1,063 Recommendation: HOLD Market Statistics Current stock price (`) 1,063 Shares O/S (cr.) 27.2

More information

I Direct. nstinct. January 4, 2018

I Direct. nstinct. January 4, 2018 I Direct nstinct January 4, 2018 I-direct Instinct Key risks to investing in I-direct Instinct It is a quick pitch note, which captures the essence of an idea in brief Instinct idea may be based on management

More information

Mahindra & Mahindra Ltd.

Mahindra & Mahindra Ltd. Nov-15 Jan-16 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 Apr-18 Jul-18 Oct-18 2QFY2019 Result Update Automobile November 15, 2018 Mahindra & Mahindra Ltd. Performance Update Y/E March (` cr)

More information

PC Jeweller (PCJEW) 417 Stepping up store expansion via small store s. Management Meet Note. ICICI Securities Ltd Retail Equity Research

PC Jeweller (PCJEW) 417 Stepping up store expansion via small store s. Management Meet Note. ICICI Securities Ltd Retail Equity Research Management Meet Note Rating matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Key Financials ( Crore) Net Sales 4,018.4 5,324.8 6,361.3 7,330.2 EBITDA 481.8 587.7 730.2 731.5

More information

Jamna Auto Industries

Jamna Auto Industries 2QFY19 Result Update Institutional Equities Jamna Auto Industries Reuters: JMNA.NS; Bloomberg: JMNA IN Performance Below Expectations; Retain Buy Due To Strong Outlook Jamna Auto s 2QFY19 earnings were

More information

Singer India (SININ) Focus on tapping small appliances segment. Management Meet Note. ICICI Securities Ltd Retail Equity Research.

Singer India (SININ) Focus on tapping small appliances segment. Management Meet Note. ICICI Securities Ltd Retail Equity Research. Management Meet Note Rating matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Key Financials Crore Revenues 118.9 155.9 196.9 243.4 285. 239.4 EBITDA.6 7.9 6.4 8.6 8.2 8. Net

More information

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics 3QFY2017 Result Update Ceramics January 25, 2017 Asian Granito Performance Highlights Quarterly Data (` cr) 3QFY17 3QFY16 % yoy 2QFY17 % qoq Revenue 247 236 4.3 265 (7.1) EBITDA 34 27 25.3 31 7.2 Margin

More information

Bajaj Finance (BAJAF) 5498

Bajaj Finance (BAJAF) 5498 Management Meet Note Rating matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Key Financials Crore FY12 FY13 FY14 FY15 NII 1,25 1,717 2,215 2,872 PPP 756 1,53 1,349 1,742 PAT

More information

UltraTech Cement (ULTCEM)

UltraTech Cement (ULTCEM) April 20, 2009 Cement Company Update UltraTech Cement (ULTCEM) Current Price Rs 546 Potential upside 15.4% Target Price Rs 630 Time Frame 12-15 months Powered by savings Historically, UltraTech Cement

More information

Wim Plast Ltd (WIMPLA) 1320

Wim Plast Ltd (WIMPLA) 1320 Company Update Rating matrix Rating : Hold Target : 1420 Target Period : 12 months Potential Upside : 8% What s changed? Target Unchanged EPS FY17E Changed from 46.4 to 46.7 EPS FY18E Introduced at 56.1

More information

Mahindra & Mahindra Ltd.

Mahindra & Mahindra Ltd. Jan-16 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 Apr-18 Jul-18 Oct-18 Jan-19 3QFY2019 Result Update Automobile February 15, 2019 Mahindra & Mahindra Ltd. Performance Update Y/E March (` cr)

More information